Additionally, higher levels of serum HMGB1 (≥ 3.83 ng/mL) were associated with longer PFS particularly in the patients with NSCLC expressing PD-L1 TPS ≥ 50%. Here, CD274 is linked to non-small cell lung carcinoma.